Barrons.com23h agoneutral
Novo Nordisk Raises Earnings Guidance. The Stock Sinks.The Danish drugmaker continues to rely on the success of semaglutide, branded as Wegovy for weight loss and Ozempic for diabetes.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
532last 24h
2516last 7d
482● bullish (7d)
255● bearish (7d)
197publishers
Zacks1d agoneutral
Pfizer (PFE) Q2 Earnings and Revenues Top EstimatesPfizer (PFE) delivered earnings and revenue surprises of +13.24% and +4.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Investopedia1d agoneutral
Here’s How Much Traders See Eli Lilly Stock Moving After EarningsEli Lilly is scheduled to report earnings Wednesday morning, with traders expecting the drugmaker’s stock could potentially approach last month’s highs following the results.
The Wall Street Journal1d agoneutral
SpaceX Earnings, Jobs Numbers: What to Watch This WeekToday Earnings (a.m.): Merck, Pfizer, McDonald's, Caterpillar, Spotify, Apollo, TPG, Marathon Petroleum, Archer-Daniels-Midland, DuPont, Kimberly-Clark Earnings (p.m.): SpaceX, Advanced Micro Devices, ...
MarketBeat1d agoneutral
Inspire Medical Systems Q2 Earnings Call HighlightsInspire Medical Systems (NYSE:INSP) reported second-quarter revenue of $200.6 million, down 7.6% from a year earlier, as coding and reimbursement disruptions continued to affect procedure volumes. The company said results exceeded its internal expectations for profitability and cash flow, prompting
Barchart3d agoneutral
Earnings, PMI and Other Key Things to Watch this WeekMarkets enter an earnings-dominated week with a huge concentration of corporate results spanning technology, industrials, healthcare, consumer discretionary, and entertainment sectors. This will provide a critical assessment of economic health and corporate fundamentals amid persistent uncertainty about technology sector valuations and AI infrastructure spending.
Investor's Business Daily5d agoneutral
AMD Stock Rebounds With Chips Ahead Of Q2 Report; SpaceX Earnings, Lockup Expiration Loom LargeAMD stock keeps its latest pullback contained compared with many other chip stocks as its second-quarter earnings report looms large.
Reuters Videos11d agoneutralVIDEO
Nasdaq lags on angst over AI spending ahead of earnings reports<body><p>STORY: U.S. stocks ended mixed on Friday, with the Dow gaining just under half a percent, the S&P 500 virtually flat and the tech-heavy Nasdaq sliding nearly two-thirds of a percent.</p><p>The S&P 500 technology index underperformed the broader market as chip stocks fell, with Intel dropping nearly 8% despite forecasting quarterly profit and revenue above Wall Street estimates.</p><p>Enthusiasm for the AI trade weakened after Alphabet's announcement earlier this week of a plan to hike capital spending even as it burns cash.</p><p>Richard Reyle, chief investment officer at Questar Capital Partners, said that as a result investors are rotating into what he called "safer parts of the market."</p><p>"Pharmaceuticals have been flying, and that's been, I think, where we see the rotation of the market right now. [FLASH] You look at the iShares, pharmaceutical fund, it's big components that are J&J and Eli Lilly, they're at all-time highs. And they're still relatively not super expensive stocks. So I think that's a place that can be bought and held. And of course, energy. Exxon's going to announce earnings next week. I bet they're going to be a blockbuster and they're going to continue to be because they make money at $60 a barrel. At $100 a barrel, forget about it. They do very well."</p><p>The S&P 500 real estate sector also outperformed during the session. Its leading gainer was Digital Realty Trust, which rallied 11% after it raised its full-year forecast for funds from operations.</p><p>Among other gainers, shares of SLB climbed 11% after the oilfield services firm beat expectations for second-quarter profit.</p><p>Investors now turn their attention to quarterly results next week from Magnificent 7 megacaps Microsoft, Amazon, Meta and Apple.</p></body>
Barchart14d agoneutral
What You Need to Know Ahead of Eli Lilly's Earnings ReleaseEli Lilly will release its second-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.
StockStory15d agoneutral
Eli Lilly (LLY): Buy, Sell, or Hold Post Q1 Earnings?Eli Lilly has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 6.5% to $1,149 per share while the index has gained 8.4%.
MT Newswires15d agoneutral
Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 AdvertisingAll three major US stock indexes were up in late-morning trading Tuesday, as investors focused on so
Investor's Business Daily40d agoneutral
Nike Stock Languishes, But Looming Earnings Report Fuels Turnaround OptimismEarnings are coming up for Nike as the company tries to engineer a turnaround, but Nike stock continues to plumb 52-week lows.
Medical Device Network76d agoneutral
Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trendsThe healthcare team covers Q1 results from pharma and medtech companies and provides a wrap-up of the key takeaways.
Moby85d agoneutral
Hims & Hers Health, Inc. Q1 2026 Earnings Call SummaryMoby summary of Hims & Hers Health, Inc.'s Q1 2026 earnings call
MarketBeat89d agoneutral
Omada Health Q1 Earnings Call HighlightsOmada Health (NASDAQ:OMDA) reported what executives described as a “milestone quarter” for the first quarter of 2026, highlighting 42% year-over-year revenue growth, expanding margins, and positive adjusted EBITDA alongside a raised full-year outlook. On the earnings call, Co-Founder and CEO Sean D
Simply Wall St.89d agoneutral
Eli Lilly's (NYSE:LLY) Earnings Are Weaker Than They SeemEli Lilly and Company's ( NYSE:LLY ) stock was strong after they recently reported robust earnings. We did some...
BioPharma Dive91d agoneutral
Novo hikes guidance on Wegovy pill’s fast sales startIn its latest earnings report, the Danish drugmaker said sales and profit should shrink less than the company originally anticipated thanks to strong prescription numbers for its new obesity pill.
Barrons.com91d agoneutral
Novo Stock Rises After Earnings. It’s Taking the Weight-Loss Drug Fight to Eli Lilly.Novo Nordisk stock rose as it raised its guidance on the back of the strong performance of its weight-loss pill.
MarketBeat91d agoneutral
Schrodinger Q1 Earnings Call HighlightsSchrodinger (NASDAQ:SDGR) reported first-quarter 2026 results and highlighted progress in its transition to hosted software licensing, growth in annual contract value (ACV), and recent business development activity tied to its drug discovery collaborations. First-quarter metrics and hosted transiti
Moby91d agoneutral
Alkermes plc Q1 2026 Earnings Call SummaryMoby summary of Alkermes plc's Q1 2026 earnings call
MarketBeat95d agoneutral
Eli Lilly and Company Q1 Earnings Call HighlightsEli Lilly and Company (NYSE:LLY) executives said the drugmaker started 2026 with “a strong start,” pointing to sharp first-quarter revenue growth, continued demand for its incretin medicines, a newly approved oral obesity therapy, and a slate of pipeline and business development milestones. Founday